None of the identified published studies contained cost information relating to the Debrisoft pad. The Soares (2009) study, which reported results from the VenUS II trial, was used to provide clinical ...
The National Institute for Health and Care Excellence recommends patented monofilament fibre technology, Debrisoft, for the treatment of acute and chronic wounds in the NHS There are 2.2 million ...
The National Institute for Health and Care Excellence (NICE) is producing guidance on the Debrisoft monofilament debridement pad for use in acute or chronic wounds in the NHS in England. The Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results